BioViros Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

BioViros General Information

Description

Provider of viral vector manufacturing services intended to accelerate access to affordable cell and gene therapies for cancer and genetic disorders. The company offers customized lentiviral vector production and purification services supported by expertise in cell biology, biologics, and CAR (Chimeric Antigen Receptor) T-cell therapy, with a focus on fostering scalable clinical applications, enabling pharmaceutical and biotechnology firms to reduce development costs, streamline therapeutic delivery, and improve patient access to treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 38 Waring Taylor Street
  • Floor 1
  • Wellington, Wellington 6011
  • New Zealand
+64 021
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 38 Waring Taylor Street
  • Floor 1
  • Wellington, Wellington 6011
  • New Zealand
+64 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioViros Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 20-Jun-2022 Completed Generating Revenue
1. Debt - General Completed Generating Revenue
To view BioViros’s complete valuation and funding history, request access »

BioViros Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioViros Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bridgewest Ventures Accelerator/Incubator Minority
To view BioViros’s complete investors history, request access »

BioViros FAQs

  • When was BioViros founded?

    BioViros was founded in 2022.

  • Where is BioViros headquartered?

    BioViros is headquartered in Wellington, New Zealand.

  • What is the size of BioViros?

    BioViros has 2 total employees.

  • What industry is BioViros in?

    BioViros’s primary industry is Biotechnology.

  • Is BioViros a private or public company?

    BioViros is a Private company.

  • What is BioViros’s current revenue?

    The current revenue for BioViros is .

  • Who are BioViros’s investors?

    Bridgewest Ventures has invested in BioViros.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process